Provided by Tiger Trade Technology Pte. Ltd.

Personalis

18.38
+1.508.89%
Post-market: 18.470.0876+0.48%19:55 EDT
Volume:8.00M
Turnover:144.91M
Market Cap:1.97B
PE:-16.75
High:18.89
Open:16.66
Low:16.62
Close:16.88
52wk High:18.89
52wk Low:4.65
Shares:107.00M
Float Shares:72.63M
Volume Ratio:1.56
T/O Rate:11.02%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.0976
EPS(LYR):-0.9107
ROE:-50.32%
ROA:-25.03%
PB:8.36
PE(LYR):-20.18

Loading ...

Personalis Q1 revenue falls but beats analyst estimates

Reuters
·
May 08

Personalis Q1 operating loss widens to $32.16 million; revenue drops 24.9% to $15.47 million

Reuters
·
May 08

BRIEF-Personalis Q1 Net Income USD -30.032 Million

Reuters
·
May 08

Personalis Q1 EPS $(0.29) Misses $(0.27) Estimate, Sales $15.472M Beat $14.483M Estimate

Benzinga Earnings
·
May 08

Personalis Inc - Sees FY2026 Revenue $78 Mln to $80 Mln

THOMSON REUTERS
·
May 08

Personalis Q1 EPS USD -0.29

THOMSON REUTERS
·
May 08

Personalis Inc expected to post a loss of 27 cents a share - Earnings Preview

Reuters
·
May 06

Personalis management to meet virtually with Lake Street

TIPRANKS
·
May 05

Press Release: Personalis to Announce First Quarter 2026 Financial Results

Dow Jones
·
Apr 24

Personalis schedules conference call to discuss first-quarter financial results

Reuters
·
Apr 24

Personalis NEOPRISM-CRC trial links early ctDNA clearance to colorectal cancer pCR

Reuters
·
Apr 21

Personalis debuts Real-Time Variant Tracker data for NeXT Personal MRD at AACR 2026

Reuters
·
Apr 13

Personalis announces annual shareholder meeting via webcast

Reuters
·
Apr 03

Personalis management to present at Needham Virtual Conference

Reuters
·
Apr 02

Personalis promotes Richard Chen to president, keeps him as CMO

Reuters
·
Mar 18

Personalis Appoints DR. Richard Chen as President to Further Accelerate Mrd Adoption

THOMSON REUTERS
·
Mar 18

Personalis’ NeXT Personal test shows predictive efficacy in breast cancer

TIPRANKS
·
Mar 12

Personalis PREDICT-DNA study links post-neoadjuvant ctDNA to 4x-9x higher breast cancer relapse risk

Reuters
·
Mar 12

Personalis Is Maintained at Equal-Weight by Morgan Stanley

Dow Jones
·
Mar 06

Personalis price target lowered to $10 from $11 at Morgan Stanley

TIPRANKS
·
Mar 05